Systematic comparison of two whole-genome amplification methods for targeted next-generation sequencing using frozen and FFPE normal and cancer tissues
Crossref DOI link: https://doi.org/10.1038/s41598-017-04419-9
Published Online: 2017-06-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mendez, Pedro
Fang, Li Tai
Jablons, David M.
Kim, Il-Jin
Text and Data Mining valid from 2017-06-22
Version of Record valid from 2017-06-22
Article History
Received: 25 May 2016
Accepted: 16 May 2017
First Online: 22 June 2017
Competing Interests
: D.M.J. and I.J.K. are equity holders and consultants of CureSeq Inc.